Literature DB >> 21518968

Notch3 is essential for regulation of the renal vascular tone.

Nada Boulos1, Frank Helle, Jean-Claude Dussaule, Sandrine Placier, Paul Milliez, Sonja Djudjaj, Dominique Guerrot, Anne Joutel, Pierre Ronco, Jean-Jacques Boffa, Christos Chatziantoniou.   

Abstract

The Notch3 receptor participates in the development and maturation of vessels. Mutations of Notch3 in humans are associated with defective regulation of cerebral blood flow. To investigate the role of Notch3 in the regulation of renal hemodynamics, we used mice lacking expression of the Notch3 gene (Notch3-/- mice). Bolus injections of norepinephrine and angiotensin II increased renal vascular resistance and decreased renal blood flow in a dose-dependent manner in wild-type mice. In sharp contrast, renal vascular resistance of Notch3-/- mice varied little after boluses of norepinephrine and angiotensin II. Inversely, bradykinin and prostacyclin relaxed renal vasculature in wild-type mice. Both vasodilators had a negligible effect on renal vascular resistance of Notch3-/- mice. Afferent arterioles freshly isolated from Notch3-/- mice displayed decreased thickness of vascular wall compared with wild -type mice and showed a deficient contractile response to angiotensin II. To examine the physiopathological consequences of the above-described deficiency, hypertension was induced by continuous infusion of angiotensin II. Angiotensin II gradually increased blood pressure in both strains, but this increase was lesser in the Notch3-/- mice. Despite this blunted systemic effect, Notch3-/- mice displayed high mortality rates (65%) attributed to heart failure. In the kidney, the surviving Notch3-/- mice showed focal structural alterations characteristic of nephroangiosclerosis. These data show that Notch3 is necessary for the adaptive response of the renal vasculature to vasoactive systems. A deficiency in the expression of Notch3 could have important physiopathological consequences in the adaptation of the cardiac and renal function to chronic increase of blood pressure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518968     DOI: 10.1161/HYPERTENSIONAHA.111.170746

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

Review 1.  Investigational Notch and Hedgehog inhibitors--therapies for cardiovascular disease.

Authors:  Eileen M Redmond; Shaunta Guha; Dermot Walls; Paul A Cahill
Journal:  Expert Opin Investig Drugs       Date:  2011-10-18       Impact factor: 6.206

Review 2.  Sirtuin 3, Endothelial Metabolic Reprogramming, and Heart Failure With Preserved Ejection Fraction.

Authors:  Heng Zeng; Jian-Xiong Chen
Journal:  J Cardiovasc Pharmacol       Date:  2019-10       Impact factor: 3.105

3.  "Yin and Yang" for Notch signaling in the mature vasculature.

Authors:  Miranda E Good; Brant E Isakson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-28       Impact factor: 4.733

Review 4.  AT1 receptor signaling pathways in the cardiovascular system.

Authors:  Tatsuo Kawai; Steven J Forrester; Shannon O'Brien; Ariele Baggett; Victor Rizzo; Satoru Eguchi
Journal:  Pharmacol Res       Date:  2017-05-17       Impact factor: 7.658

5.  Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension.

Authors:  Yosu Luque; Olivia Lenoir; Philippe Bonnin; Lise Hardy; Anna Chipont; Sandrine Placier; Sophie Vandermeersch; Yi-Chun Xu-Dubois; Blaise Robin; Hélène Lazareth; Michèle Souyri; Léa Guyonnet; Véronique Baudrie; Eric Camerer; Eric Rondeau; Laurent Mesnard; Pierre-Louis Tharaux
Journal:  J Am Soc Nephrol       Date:  2017-09-19       Impact factor: 10.121

Review 6.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

7.  Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.

Authors:  Fala El Machhour; Zela Keuylian; Panagiotis Kavvadas; Jean-Claude Dussaule; Christos Chatziantoniou
Journal:  J Am Soc Nephrol       Date:  2014-11-24       Impact factor: 10.121

8.  Hemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension.

Authors:  Aaron J Polichnowski; Karen A Griffin; Maria M Picken; Hector Licea-Vargas; Jianrui Long; Geoffrey A Williamson; Anil K Bidani
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-04

9.  Notch transcriptional control of vascular smooth muscle regulatory gene expression and function.

Authors:  Sanchita Basu; Dinesh Kumar Srinivasan; Ke Yang; Hema Raina; Suhanti Banerjee; Rongli Zhang; Steven A Fisher; Aaron Proweller
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

10.  Fibrosis and Immune Cell Infiltration Are Separate Events Regulated by Cell-Specific Receptor Notch3 Expression.

Authors:  Sabine Brandt; Tobias M Ballhause; Anja Bernhardt; Annika Becker; Delia Salaru; Hien Minh Le-Deffge; Alexander Fehr; Yan Fu; Lars Philipsen; Sonja Djudjaj; Andreas J Müller; Rafael Kramann; Mahmoud Ibrahim; Robert Geffers; Chris Siebel; Berend Isermann; Florian H Heidel; Jonathan A Lindquist; Peter R Mertens
Journal:  J Am Soc Nephrol       Date:  2020-08-28       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.